Gouveia, MFiorentino, FJesus, GCosta, JBorges, M2019-04-082019-04-082017Pediatr Infect Dis J. 2017 Aug;36(8):782-787http://hdl.handle.net/10400.17/3234Pneumococcal infections are the leading cause of vaccine-preventable death in children. In June 2015, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the Portuguese Immunization Program. We evaluated the cost-effectiveness of children vaccinated with PCV13 versus no vaccination for preventing pneumococcal diseases.engChild, PreschoolCost-Benefit AnalysisHumansIncidenceInfantImmunizationModels, ImmunologicalPneumococcal InfectionsPneumococcal VaccinesCHLC FARjournal article10.1097/INF.0000000000001587